These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16769923)

  • 1. Does late gadolinium enhancement predict cardiac events in patients with ischemic cardiomyopathy?
    Mandapaka S; D'Agostino R; Hundley WG
    Circulation; 2006 Jun; 113(23):2676-8. PubMed ID: 16769923
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed enhancement morphology on cardiac magnetic resonance imaging is correlated with signal-averaged electrocardiogram and QT dispersion in myocardial infarction.
    Takase B; Nagata M
    Angiology; 2009; 60(4):412-8. PubMed ID: 19124453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging.
    Kelle S; Roes SD; Klein C; Kokocinski T; de Roos A; Fleck E; Bax JJ; Nagel E
    J Am Coll Cardiol; 2009 Nov; 54(19):1770-7. PubMed ID: 19874990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peri-infarct ischemia determined by cardiovascular magnetic resonance evaluation of myocardial viability and stress perfusion predicts future cardiovascular events in patients with severe ischemic cardiomyopathy.
    Tsukiji M; Nguyen P; Narayan G; Hellinger J; Chan F; Herfkens R; Pauly JM; McConnell MV; Yang PC
    J Cardiovasc Magn Reson; 2006; 8(6):773-9. PubMed ID: 17060098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
    Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
    J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions.
    Hartke LP; Gilkeson RC; O'Riordan MA; Siwik ES
    Congenit Heart Dis; 2006 Sep; 1(5):192-201. PubMed ID: 18377526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of late gadolinium enhancement magnetic resonance imaging in patients with cardiomyopathy.
    Stirrat J; White JA
    Can J Cardiol; 2013 Mar; 29(3):329-36. PubMed ID: 23439019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.
    Silva C; Moon JC; Elkington AG; John AS; Mohiaddin RH; Pennell DJ
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1076-9. PubMed ID: 18163027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience.
    Soriano CJ; Ridocci F; Estornell J; Pérez-Boscá JL; Pomar F; Trigo A; Planas A; Nadal M; Jacas V; Martinez V; Paya R
    Int J Cardiol; 2007 Mar; 116(2):167-73. PubMed ID: 16828180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of transient new-onset atrial fibrillation during vascular surgery.
    Winkel TA; Schouten O; Hoeks SE; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2009 Dec; 38(6):683-8. PubMed ID: 19683947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac magnetic resonance evaluation of myocardial viability and ischemia.
    Strzelczyk J; Attili A
    Semin Roentgenol; 2008 Jul; 43(3):193-203. PubMed ID: 18486681
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
    J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
    Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy.
    Romero-Puche A; Marín F; González-Carrillo J; García-Honrubia A; Climent V; Feliu E; Ruiz-Espejo F; Payá E; Gimeno-Blanes JR; de la Morena G; Valdés-Chavarri M
    Rev Esp Cardiol; 2008 Aug; 61(8):853-60. PubMed ID: 18684368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.